As a leading expert in biopharma and technological innovation, Ivan Kairatov has dedicated his career to the intersection of health and R&D. Today, we delve into a groundbreaking study where artificial intelligence analyzed WhatsApp voice messages to detect major depressive disorder, a condition
In a significant move that could reshape the landscape of cardiovascular medicine for millions of Americans, a comprehensive bipartisan appropriations bill is advancing through Congress, carrying with it major implications for how patients access care and how the nation invests in medical research.
We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and research is pushing the boundaries of what’s possible in patient care. We'll be exploring a groundbreaking AI-powered wearable that translates silent throat movements into fluent speech for
A groundbreaking therapeutic strategy that combines a systemic targeted drug with a standard locoregional treatment is showing unprecedented promise in preventing the recurrence of hepatocellular carcinoma (HCC) among high-risk patients who have undergone surgery. This comprehensive analysis of a
The intricate code of our DNA contains a deeply personal story, one that extends far beyond physical traits like eye color and height to map out potential health challenges that may lie dormant for years. For decades, the medical community has viewed this genetic map reactively, often waiting for
In the critical moments of treating a suspected opioid overdose, where every second counts, a new study reveals that a common vital sign could be the key to uncovering a hidden and far more complex danger. A groundbreaking investigation suggests that an unusually slow pulse might be the first clear
The promise of affordable elective surgery in an exotic location has captivated a growing number of patients, but a closer examination reveals a far more complex and costly reality hidden behind the glossy brochures and enticing online advertisements. This burgeoning global industry, built on the
We sit down with Biopharma expert Ivan Kairatov to discuss a recent study that uncovers a critical vulnerability in acute myeloid leukemia (AML), a notoriously difficult-to-treat blood cancer. This research zeroes in on the survival mechanisms of resilient leukemia stem cells, identifying a key
Today we're joined by Ivan Kairatov, a Biopharma expert at the forefront of integrating technology and innovation into medical training. We’ll be exploring a groundbreaking initiative that uses ambient AI to transform medical education, moving from sporadic feedback to a model where every clinical
Today we sit down with Dr. Ivan Kairatov, a veteran biopharma expert whose work at the intersection of medicinal chemistry and computational biology is pushing the boundaries of treatment for central nervous system disorders. For decades, the neurokinin-1 receptor, or NK1R, was a tantalizing but
